CAMK2G and central nervous system cancer: Consistent with the hypothesis that BDNF functions to modulate synaptic strength through the CAMKII calcium signalling pathway, the CAMKII inhibitor KN-93 blocks the effect of BDNF on glioma glutamatergic current amplitude, whereas the inactive analogue KN-92 does not (Fig. 2d,e).